| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |